Toward Continuous Neurocognitive Monitoring: Integrating Speech AI with Relational Graph Transformers for Rare Neurological Diseases
This could transform episodic neurology into continuous personalized monitoring for millions of patients with rare neurological diseases, though it is incremental as it builds on existing speech AI and transformer methods.
The paper tackled the problem of monitoring cognitive symptoms in rare neurological diseases by proposing continuous neurocognitive monitoring using smartphone speech analysis integrated with Relational Graph Transformers. In a proof-of-concept with phenylketonuria, speech-derived proficiency correlated with blood phenylalanine (p = -0.50, p < 0.005) but not with standard cognitive tests.
Patients with rare neurological diseases report cognitive symptoms -"brain fog"- invisible to traditional tests. We propose continuous neurocognitive monitoring via smartphone speech analysis integrated with Relational Graph Transformer (RELGT) architectures. Proof-of-concept in phenylketonuria (PKU) shows speech-derived "Proficiency in Verbal Discourse" correlates with blood phenylalanine (p = -0.50, p < 0.005) but not standard cognitive tests (all |r| < 0.35). RELGT could overcome information bottlenecks in heterogeneous medical data (speech, labs, assessments), enabling predictive alerts weeks before decompensation. Key challenges: multi-disease validation, clinical workflow integration, equitable multilingual deployment. Success would transform episodic neurology into continuous personalized monitoring for millions globally.